Table 1.
Antibody | Age (mo) | No. of mice of each genotype |
|
---|---|---|---|
Control | KO | ||
Anti-MECR (IHC) | 3 | 6 | 4 |
6 | 11 | 15 | |
9 | 6 | 9 | |
11 | 4 | 5 | |
Anti- GFAP (IHC) | 3 | 4 | 4 |
6 | 4 | 4 | |
9 | 4 | 4 | |
11 | 4 | 4 | |
Anti-Iba (IHC) | 3 | 4 | 4 |
6 | 8 | 7 | |
9 | 4 | 4 | |
11 | 4 | 4 | |
Anti-Calbindin (IHC) | 3 | 4 | 4 |
6 | 7 | 8 | |
9 | 4 | 4 | |
11 | 4 | 4 | |
Anti-LA (IHC) | 6 | 19 | 14 |
Anti-SSBP1 (IHC) | 6 | 15 | 10 |
Anti-COX1 (IHC) | 6 | 4 | 4 |
Anti-8-isoprostane (IHC) | 6 | 6 | 6 |
Anti-nitrotyrosine (IHC) | 6 | 8 | 8 |
Anti-caspase3 (IHC) | 6 | 4 | 4 |
Anti-MECR (IF) | 3 | 4 | 4 |
6 | 4 | 4 | |
9 | 4 | 6 | |
11 | 4 | 5 | |
Anti-calbindin (IF) | 3 | 4 | 4 |
6 | 4 | 4 | |
9 | 4 | 6 | |
11 | 4 | 5 | |
Anti-LA (IF) | 3 | 4 | 4 |
6 | 4 | 4 | |
9 | 4 | 6 | |
11 | 4 | 5 |